Dr. Charlotte Ruth Gamble, MD

Dr. Gamble practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Gamble's NPI, 1215356787, was assigned on April 14, 2014. Dr. Gamble holds District of Columbia license MD20000066.

Dr. Gamble's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Gamble's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dr. Gamble is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Gamble to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gamble practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Gamble's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Gamble is licensed in District of Columbia.

CMS data shows 149 Medicare services from Dr. Gamble across 3 procedure codes in 2024, all of them office visits, for 94 Medicare patients. Medicare paid $17,020 for them.

CMS counts 94 Medicare patients who saw Dr. Gamble in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gamble's median patient age at 61, with 98% women.

In 2024, Dr. Gamble wrote 130 Medicare Part D claims for 42 patients. 75% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $10,929 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Gamble for performance year 2024, reported as part of a group. Dr. Gamble accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gamble as offering telehealth. CMS counts 18 procedures of removal of the uterus by Dr. Gamble, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Gamble, published from 2014 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Laparoscopy, Ovarian Neoplasms and Carcinoma, Ovarian Epithelial. Dr. Gamble has published most often in Gynecol Oncol. Dr. Gamble's most frequent co-authors are Jason D. Wright, MD, Eloise Chapman-Davis, MD and Melissa Kristen Frey, MD.

CMS Open Payments shows 25 general payments to Dr. Gamble from 9 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $179.